We are a company made up by a multidisciplinary team focused on the study and development of a new synthetic particle for its use on bone defects resulting from tumoral, cystic or traumatic injuries.
Surgical management of patients with bone defects as a result of tumors, cysts, malformation or traumatic injuries is a frequent problem in traumatology, maxillofacial surgery and implantology due to the complexity of the surgical intervention and its recovery.
Our solution is to manufacture particles of small size and specific geometries that have a calculated porosity for bone regeneration and competitive costs.
We create state-of-the-art digital projects and test its mechanical, chemical and biological properties on the lab.
In order to present the two winning technologies of Global UC 2019 before a committee of experts, the Transfer Office has met with industry experts to share their comments with the research teams before to their trip to Boston.
A multidisciplinary team, made up by young and senior researchers, focused on developing and innovating with new therapies and solutions, from the laboratory to the clinic.